Toficalm: UK Status and Risks
Toficalm is not UK-licensed for any use in the UK. It may still appear in some listings, but no MHRA review of its safety or effectiveness covers it.
Check with a pharmacist before relying on it, and treat bold marketing claims about it with caution. An unclear licensing status is a reasonable thing to question.
Not UK-licensed. This medicine is not supplied through UK-registered pharmacies.
Sellers list the active ingredient as tofisopam. The MHRA has not assessed what these products actually contain.
The MHRA warns that medicines sold outside registered pharmacies can be counterfeit, contaminated, or contain the wrong amount of active ingredient. Buy prescription-only medicines from a pharmacy registered in the UK.
Pharmacies by area for Toficalm (UK-licensed equivalent)
- North East · 884 pharmacies
- North West · 2538 pharmacies
- Yorkshire and The Humber · 1676 pharmacies
- East Midlands · 1307 pharmacies
- West Midlands · 1778 pharmacies
- East of England · 1860 pharmacies
- London · 3261 pharmacies
- South East · 2368 pharmacies
- South West · 1374 pharmacies
- Northern Ireland · 714 pharmacies
- Scotland · 1725 pharmacies
- Wales · 1050 pharmacies
Pharmacies near you
Use your location to open the pharmacies closest to you and ask them about Toficalm, the UK-licensed medicine with the same active ingredient.
Cities with the most pharmacies
- London · 724 pharmacies
- Birmingham · 265 pharmacies
- Nottingham · 180 pharmacies
- Glasgow · 177 pharmacies
- Leeds · 173 pharmacies
- Sheffield · 162 pharmacies
- Bristol · 148 pharmacies
- City of London · 144 pharmacies
- Manchester · 134 pharmacies
- Edinburgh · 131 pharmacies
- Bolton · 124 pharmacies
- Belfast · 122 pharmacies
- Hampstead · 121 pharmacies
- Coventry · 115 pharmacies
- Cardiff · 112 pharmacies
About Toficalm
Toficalm is not a licensed medicine in the United Kingdom and cannot legally be sold there as a medicine. Its active ingredient, intended use and strengths are not established here, so its effects and safety cannot be assessed reliably. A doctor or pharmacist can discuss the advertised product and appropriate treatment options for the concern that prompted interest in it.
Claimed strengths are manufacturer claims, but no specific strength or dosage form is identified for Toficalm. There is no established label-based dosage to describe. A product name alone cannot establish the amount of an active ingredient, and no licensed equivalent is identified here for a strength comparison.
How Toficalm works
Toficalm's active ingredient is not identified and its pharmacological class is not established. A meaningful explanation of how it works therefore cannot be given.
Medicines can act through different pathways, such as changing chemical signalling or blocking particular receptors, but attributing any of these mechanisms to Toficalm would be speculation. Its name does not establish its ingredients, expected effects or similarity to another medicine.
What Toficalm is used for
No specific marketed use is identified for Toficalm, so there is no clear treatment claim to describe or assess. Its name alone does not establish which symptoms or conditions it is intended to address.
Advertising claims should not be treated as evidence that a product is effective or suitable for an individual. A doctor or pharmacist can discuss any claims shown on its packaging or advertising and explain appropriate treatment options.
Key warnings
- Not licensed as a medicine in the United Kingdom; its contents and quality are not independently verified here.
- The active ingredient is unidentified, so ingredient-specific safety warnings cannot be established.
- The dosage form and strength are not established, preventing a reliable assessment of exposure.
- Unknown ingredients make it difficult to assess suitability alongside existing medicines or health conditions.
Main interactions
- Interactions with prescription medicines cannot be assessed because the active ingredient is unidentified.
- Interactions with over-the-counter medicines and herbal products cannot be established.
- Possible interactions with alcohol cannot be assessed; absence of interaction information does not establish safety.
Storage
No storage conditions or dosage form are identified for Toficalm. General precautions include keeping products in their original packaging, away from children and pets, and following any storage directions on the label to maintain quality.
Missed dose
No missed-dose guidance can be established for Toficalm because its active ingredient and dosing schedule are unidentified. Advice for another medicine should not be assumed to apply. A doctor or pharmacist can assess the packaging and circumstances before recommending an appropriate next step.
Pregnancy and breastfeeding
The marketing material does not specify pregnancy or breastfeeding data for Toficalm. With no identified active ingredient, risks during pregnancy or lactation cannot be assessed. Suitability should be discussed with a doctor or pharmacist, rather than inferred from the product name or advertising.
Related medicines
First published October 2, 2026 · Last updated · Report an error on this page